<DOC>
	<DOCNO>NCT01073891</DOCNO>
	<brief_summary>The purpose study describe pharmacokinetics new oral liquid moxifloxacin formulation influence concommitant food intake pharmacokinetics healthy adult compare marketed oral tablet . Pharmacokinetics see body absorbs , distribute get rid study drug . The absorption drug administer different dosage form may alter due influence different excipients use . The safety moxifloxacin administer oral liquid formulation also look . Results study use guide dose strategy large clinical trial plan child .</brief_summary>
	<brief_title>Bioavailability , Food Effect Safety , Tolerability New Oral Suspension Comparison Marketed Moxifloxacin Tablet Healthy Adults</brief_title>
	<detailed_description />
	<mesh_term>Moxifloxacin</mesh_term>
	<mesh_term>Fluoroquinolones</mesh_term>
	<mesh_term>Norgestimate , ethinyl estradiol drug combination</mesh_term>
	<criteria>Healthy male female subject ; Age : 18 55 year ( inclusive ) Body mass index ( BMI ) : above/equal 18 below/equal 30 kg/mÂ² ; Women childbearing age must negative pregnancy test must use adequate contraception throughout study 4 week afterwards Clinically relevant finding ECG Incompletely cure preexisting disease assume absorption , distribution , metabolism , elimination effect study drug normal Known hypersensitivity moxifloxacin , quinolones excipients Known severe allergy , nonallergic drug reaction , multiple drug allergy Relevant diseases within last 4 week prior first study drug administration Febrile illness within 1 week first study drug administration Patients history tendon disease/disorder related quinolone treatment . Congenital document acquire QT prolongation Regular use medicine ( exception contraceptive ) Pregnancy lactation Regular use therapeutic recreational drug Smoking 25 cigarette daily Regular daily consumption 500 mL usual beer equivalent quantity approximately 20 g alcohol another form Suspicion drug alcohol abuse Special diet prevent subject eat standard meal study Regular daily consumption 1 L xanthincontaining beverage Donation 100 mL blood within 4 week first study drug administration approximately 500 mL precede 3 month</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>June 2015</verification_date>
	<keyword>Pharmacokinetics</keyword>
	<keyword>Bioavailability</keyword>
	<keyword>Food effect</keyword>
	<keyword>Oral liquid formulation</keyword>
</DOC>